Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The BAFF-var Polymorphism as a Biomarker of Response to B-depletive Treatment in Patients Affected by Systemic Lupus Erythematosus and Rheumatoid Arthritis: a Prospective Study

NCT05659407 is registered in ClinicalTrials.gov with University of Cagliari as lead sponsor.

NCT NCT05659407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05659407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The BAFF-var Polymorphism as a Biomarker of Response to B-depletive Treatment in Patients Affected by Systemic Lupus Erythematosus and Rheumatoid Arthritis: a Prospective Study
Lead sponsor
University of Cagliari
Phase
Observational
Overall status
Unknown status
Start date
July 24, 2020
Completion date
January 31, 2023
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blys polymorphism, rheumatoid arthritis, systemic lupus erythematosus